Omada Health has named Eli Lilly and Co. executive Wei-Li Shao chief commercial officer. He has been with Lilly for 18 years and most recently served as vice president of the company's USA neuroscience business unit. Shao also served as general manager of Lilly New Zealand and Lilly Taiwan, as well as vice president of Lilly China Diabetes. He holds an MBA from Indiana University’s Kelley School of Business.